Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Recommended Doses and Injection Schedule Clinical trials have used once-weekly subcutaneous doses ranging from approximately 1 mg to 12 mg, escalated gradually under medical supervision
Type 2 Diabetes Prevalence and Etiology T2D is a common metabolic disorder characterized by major dysregulations in glucose homeostasis
HR departments can provide details about wellness programs that may cover these medications even when standard insurance excludes them
Common GLP-1 Medications include: Semaglutide: Ozempic (Injection): Approved for Type 2 diabetes Wegovy (Injection): Approved for weight loss Rybelsus (Oral Tablet): Approved for Type 2 diabetes Tirzepatide (Note: Dual GLP-1/GIP receptor agonist): Mounjaro (Injection): Approved for Type 2 diabetes Zepbound (Injection): Approved for weight loss Liraglutide: Victoza (Injection): Approved for Type 2 diabetes Saxenda (Injection): Approved for weight loss Dulaglutide: Trulicity (Injection): Approved for Type 2 diabetes Exenatide: Byetta (Injection, short-acting) Bydureon BCise (Injection, long-acting) Lixisenatide: Adlyxin (Injection) Do GLP-1 Medications Help Cosmetic Surgery
Dosing The dosing of Zepbound typically follows a gradual increase over time to allow the body to adjust and lessen the occurrence of the side effects
Natarelli N, et al
US$ 29.04
US$ 25.39
US$ 25.10
US$ 22.50
US$ 25.48
